-
1
-
-
33846266252
-
Prognostic markers in triple-negative breast cancer
-
Rakha E., El-sayed M., Green A., et al. Prognostic markers in triple-negative breast cancer. Cancer 2007, 109:25-32.
-
(2007)
Cancer
, vol.109
, pp. 25-32
-
-
Rakha, E.1
El-sayed, M.2
Green, A.3
-
2
-
-
58149340543
-
Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer
-
Dowsett M., Dunbier A. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clin Cancer Res 2008, 14:8019-8026.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 8019-8026
-
-
Dowsett, M.1
Dunbier, A.2
-
3
-
-
0034680102
-
Molecular portraits of human breast tumours
-
Perou C., Sorlie T., Eisen M., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
-
(2000)
Nature
, vol.406
, pp. 747-752
-
-
Perou, C.1
Sorlie, T.2
Eisen, M.3
-
4
-
-
0042838307
-
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
-
Sotiriou C., Neo S., McShane L., et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003, 100:10393-10398.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 10393-10398
-
-
Sotiriou, C.1
Neo, S.2
McShane, L.3
-
5
-
-
33746709476
-
Steroid hormone receptor status of mouse mammary stem cells
-
Asselin-Labat M., Shackleton M., Stingl J., et al. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 2006, 98:1011-1014.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 1011-1014
-
-
Asselin-Labat, M.1
Shackleton, M.2
Stingl, J.3
-
6
-
-
34547982817
-
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
-
Tischkowitz M., Brunet J., Begin L., et al. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer 2007, 7:134-138.
-
(2007)
BMC Cancer
, vol.7
, pp. 134-138
-
-
Tischkowitz, M.1
Brunet, J.2
Begin, L.3
-
7
-
-
38049051926
-
Immunohistochemical categorisation of ductal carcinoma in situ of the breast
-
Meijnen P., Peterse J., Antonini N., Rutgers E., Van D. Immunohistochemical categorisation of ductal carcinoma in situ of the breast. Br J Cancer 2008, 98:137-142.
-
(2008)
Br J Cancer
, vol.98
, pp. 137-142
-
-
Meijnen, P.1
Peterse, J.2
Antonini, N.3
Rutgers, E.4
Van, D.5
-
8
-
-
69949125582
-
The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast cancer
-
Seung J., Woohee J., Joon J. The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast cancer. Jpn J Clin Oncol 2009, 39(9):560-568.
-
(2009)
Jpn J Clin Oncol
, vol.39
, Issue.9
, pp. 560-568
-
-
Seung, J.1
Woohee, J.2
Joon, J.3
-
9
-
-
78651446711
-
Expression and clinical significance of androgen receptor in triple negative breast cancer
-
Xiang L., YanXia S., ZhiMing L., WenQi J. Expression and clinical significance of androgen receptor in triple negative breast cancer. Chin J Cancer 2010, 29:123-129.
-
(2010)
Chin J Cancer
, vol.29
, pp. 123-129
-
-
Xiang, L.1
YanXia, S.2
ZhiMing, L.3
WenQi, J.4
-
10
-
-
0042071592
-
Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies
-
Moinfar F., Okcu M., Tsybrovskyy O., et al. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 2003, 98:703-711.
-
(2003)
Cancer
, vol.98
, pp. 703-711
-
-
Moinfar, F.1
Okcu, M.2
Tsybrovskyy, O.3
-
11
-
-
65249139954
-
Mutations and prognosis in breast cancer androgen receptor levels and association with PIK3CA
-
Ana M., Katherine S., Shana L., et al. Mutations and prognosis in breast cancer androgen receptor levels and association with PIK3CA. Clin Cancer Res 2009, 15:2472-2478.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2472-2478
-
-
Ana, M.1
Katherine, S.2
Shana, L.3
-
12
-
-
76349117455
-
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
-
Leo A., David J., Sushil B., Joan M., Rohit B. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol 2010, 23:205-212.
-
(2010)
Mod Pathol
, vol.23
, pp. 205-212
-
-
Leo, A.1
David, J.2
Sushil, B.3
Joan, M.4
Rohit, B.5
-
13
-
-
33745603978
-
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
-
Doane A., Danso M., Lal P., et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 2006, 25:3994-4008.
-
(2006)
Oncogene
, vol.25
, pp. 3994-4008
-
-
Doane, A.1
Danso, M.2
Lal, P.3
-
14
-
-
44949129660
-
Androgen receptor expression in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloprotenases and their inhibitors
-
Gonzalez L., Cortel M., Vazquez J., et al. Androgen receptor expression in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloprotenases and their inhibitors. J BMC Cancer 2008, 8:149-155.
-
(2008)
J BMC Cancer
, vol.8
, pp. 149-155
-
-
Gonzalez, L.1
Cortel, M.2
Vazquez, J.3
-
15
-
-
54849414696
-
Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
-
Ogawa Y., Hai E., Matsumoto K., et al. Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers. Int J Clin Oncol 2008, 13:431-435.
-
(2008)
Int J Clin Oncol
, vol.13
, pp. 431-435
-
-
Ogawa, Y.1
Hai, E.2
Matsumoto, K.3
-
16
-
-
77649188673
-
Expression of androgen receptors in primary breast cancer
-
Park S., Koo J., Park H., et al. Expression of androgen receptors in primary breast cancer. Ann Oncol 2010, 21:488-492.
-
(2010)
Ann Oncol
, vol.21
, pp. 488-492
-
-
Park, S.1
Koo, J.2
Park, H.3
-
17
-
-
0026033066
-
Staging and follow up of breast cancer patients
-
Kinne D. Staging and follow up of breast cancer patients. Cancer 1991, 67:1196-1198.
-
(1991)
Cancer
, vol.67
, pp. 1196-1198
-
-
Kinne, D.1
-
18
-
-
33847147313
-
American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
Wolff A., Hammond M., Schwartz J., et al. American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007, 25:118-145.
-
(2007)
J Clin Oncol
, vol.25
, pp. 118-145
-
-
Wolff, A.1
Hammond, M.2
Schwartz, J.3
-
19
-
-
0032896905
-
Estrogen receptor status by immunohistochemistry is superior to the legend binding assay for predicting response to adjuvant endocrine therapy in breast cancer
-
Harvey J., Clark G., Osborne C., et al. Estrogen receptor status by immunohistochemistry is superior to the legend binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999, 17:1474-1481.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1474-1481
-
-
Harvey, J.1
Clark, G.2
Osborne, C.3
-
20
-
-
39549088717
-
Androgen receptor as a target for the treatment of hormone receptor negative breast cancer: an unchartered territory
-
Nahleh Z. Androgen receptor as a target for the treatment of hormone receptor negative breast cancer: an unchartered territory. Future Oncol 2008, 4:15-21.
-
(2008)
Future Oncol
, vol.4
, pp. 15-21
-
-
Nahleh, Z.1
-
21
-
-
44849106397
-
Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast
-
Cho L., Hsu Y. Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast. Kaohsiung J Med Sci 2008, 24:227-232.
-
(2008)
Kaohsiung J Med Sci
, vol.24
, pp. 227-232
-
-
Cho, L.1
Hsu, Y.2
-
22
-
-
33744960226
-
Race, breast cancer subtypes, and survival in the Carolina breast cancer study
-
Carey L., Perou C., Livasy C., et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 2006, 295:2492-2502.
-
(2006)
JAMA
, vol.295
, pp. 2492-2502
-
-
Carey, L.1
Perou, C.2
Livasy, C.3
-
23
-
-
33846266252
-
Prognostic markers in triple-negative breast cancer
-
Rakha E.A., Maysa E., et al. Prognostic markers in triple-negative breast cancer. Cancer 2007, 109:25-32.
-
(2007)
Cancer
, vol.109
, pp. 25-32
-
-
Rakha, E.A.1
Maysa, E.2
|